Set realistic expectations either way: injection remains the most evidence-supported delivery format for both semaglutide and tirzepatide
Stress Management: Chronic stress creates a constant state of oxidative pressure
The fact that covering GLP-1s under Medicare Part D for authorized uses is already making a mark on total Part D program spending could be a sign of even higher spending to come as Part D plans are now able to cover Wegovy for its heart health benefits, as other uses for GLP-1s are approved, and as policymakers consider legislation that would authorize Medicare to cover obesity drugs
The prescribing information recommends a gradual dose escalation approach to minimise gastrointestinal side effects, which are the most commonly reported adverse reactions
For weight management, research indicates that tirzepatide produces superior weight loss compared to semaglutide, with patients losing 20.2% of body weight versus 13.7%, respectively
Moreover, there were multiple components of this machinery also represented in the upregulated proteome
